Market Overview

UPDATE: Wedbush Downgrades Illumina to Neutral on Risk/Reward

Related ILMN
Markets Surge; McDonald's Posts Lower Sales
Benzinga's Top Upgrades
Making Money With Charles Payne: 09/26/14 (Fox Business)

Wedbush reduced its rating on Illumina (NASDAQ: ILMN) from Outperform to Neutral and reiterated its $52 price target.

Wedbush noted, "We have spoken with several typical sequencing customers recently that are either putting off or second guessing HiSeq purchases because of the attractive price point of ILMN's own sequencing service. In addition, for the first time, we are hearing about instances of used HiSeq 2000's for sale on the secondary market at steep discounts. On a positive note, near-term project pipelines appear robust and, despite continued MiSeq teething pains, feedback remains largely positive to date, with plans for greater utilization by core labs in 2013."

Illumina closed at $55.55 on Thursday.

Latest Ratings for ILMN

DateFirmActionFromTo
Oct 2014Credit Suisse
Oct 2014Cantor Fitzgerald
Oct 2014Bank of America

View More Analyst Ratings for ILMN
View the Latest Analyst Ratings

Posted-In: WedbushAnalyst Color Downgrades Intraday Update Analyst Ratings

 

Related Articles (ILMN)

Around the Web, We're Loving...

Get Benzinga's Newsletters